Work

Tumor microenvironment associated with increased pretreatment density of activated PD-1+ LAG-3+/− TIM-3− CD8+ T cells facilitates clinical response to axicabtagene ciloleucel (axi-cel) in patients (pts) with large B-cell lymphoma.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.3022

Authors: Jerome Galon, Nathalie Scholler, Regis Perbost, Sarah Turcan, Corinne Danan, Frederick Lundry Locke, Sattva Swarup Neelapu, David Bernard Miklos, Caron A. Jacobson, Lazaros J. Lekakis, Yi Lin, Armin Ghobadi, Justin Chou, Zixing Wang, Allen Xue, John M. Rossi, Adrian Bot

Institutions: Kite (United States), Moffitt Cancer Center, The University of Texas MD Anderson Cancer Center, Stanford Medicine, Stanford University, Dana-Farber Cancer Institute, University of Miami, Sylvester Comprehensive Cancer Center, Mayo Clinic, Washington University in St. Louis

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3029948752

Cites:

Cited by: 7

Related to: 10